Novo Nordisk – Are You Yourself?

Novo Nordisk is on the cusp of launching their new indication for semaglutide in Alzheimer's Disease, which can be effective in slowing the onset of disease - but only if Alzheimer's is identified and treated early.

The brief for this campaign was to encourage higher recognition of the potential early signs of Alzheimer's Disease in both people with the condition and with caregivers.

The idea was focused around the fact that we all know what our normal is. Using an emotive copy construct, we ask people to question the odd situations they find themselves or a loved one in, and ask - if they're not quite themselves, it might be aging... but could it be Alzheimer's?